Anke Pisters-van Roy | MD
CZ

Anke Pisters-van Roy, MD, CZ is a dedicated and passionate healthcare professional with a strong background in orphan drug development and advocacy. With a medical degree and expertise in the field, Anke has made significant contributions to the orphan drug industry through her work at CZ, a leading healthcare insurance provider.

Anke's experience and knowledge in orphan drug development have positioned her as a key opinion leader in the industry. She has a proven track record of driving strategy and fostering partnerships to advance the development and accessibility of orphan drugs for patients in need. Anke's commitment to improving the lives of individuals with rare diseases is evident in her advocacy efforts and innovative approaches to addressing the unique challenges faced by this patient population. She is co-founder of the Orphan Drugs Access Pilot (ODAP).
As a speaker at the World Orphan Drug Congress 2025, Anke will share her insights on the latest trends, strategies, and opportunities in the orphan drug industry. Her expertise in navigating the complex landscape of orphan drug development, reimbursement, and access will provide valuable perspectives for attendees looking to make a positive impact in this critical area of healthcare.

Anke's collaborative approach, combined with her deep understanding of the orphan drug ecosystem, makes her a sought-after expert for industry events and initiatives. Her dedication to driving innovation and improving patient outcomes sets her apart as a leader in the orphan drug industry, and her participation in the World Orphan Drug Congress 2025 is sure to inspire and inform attendees from around the globe.